Page last updated: 2024-10-24

busulfan and Cockayne-Touraine Disease

busulfan has been researched along with Cockayne-Touraine Disease in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Recessive dystrophic epidermolysis bullosa is a severe, incurable, inherited blistering disease caused by COL7A1 mutations."1.42Reduced Toxicity Conditioning and Allogeneic Hematopoietic Progenitor Cell Transplantation for Recessive Dystrophic Epidermolysis Bullosa. ( Baxter-Lowe, L; Bruckner, A; Cairo, MS; Chen, M; Christiano, AM; Fabricatore, S; Geyer, MB; Giller, R; Harel, S; Kandel, J; Kiuru, M; LeBoeuf, N; McGrath, J; Morel, KD; Radhakrishnan, K; Uitto, J; Umegaki, N; Woodley, D, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Geyer, MB1
Radhakrishnan, K1
Giller, R1
Umegaki, N1
Harel, S1
Kiuru, M1
Morel, KD1
LeBoeuf, N1
Kandel, J1
Bruckner, A1
Fabricatore, S1
Chen, M1
Woodley, D1
McGrath, J1
Baxter-Lowe, L1
Uitto, J1
Christiano, AM1
Cairo, MS1

Other Studies

1 other study available for busulfan and Cockayne-Touraine Disease

ArticleYear
Reduced Toxicity Conditioning and Allogeneic Hematopoietic Progenitor Cell Transplantation for Recessive Dystrophic Epidermolysis Bullosa.
    The Journal of pediatrics, 2015, Volume: 167, Issue:3

    Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Busulfan; Child; Collagen Type VII; Epidermolysis Bu

2015